European Malaria Vaccine Initiative

Copenhagen, Denmark

European Malaria Vaccine Initiative

Copenhagen, Denmark
SEARCH FILTERS
Time filter
Source Type

Imoukhuede E.B.,European Malaria Vaccine Initiative | Ventura R.,European Malaria Vaccine Initiative | Imbault N.,European Malaria Vaccine Initiative | Van Schooten H.,European Malaria Vaccine Initiative | Leroy O.,European Malaria Vaccine Initiative
Human Vaccines | Year: 2010

Over the past ten years, EMVI has continually strived to maintain its main goal of accelerating the development of candidate malaria vaccines by facilitating the translational gap between promising experimental malaria vaccines and subsequent clinical trials in Europe and in Africa. To date, EMVI has funded approximately ten vaccine formulations (antigen-adjuvant combination) by developing GMP materials and sponsoring subsequent human clinical trials. In recent years EMVI's role has expanded into harmonisation activities relevant to malaria vaccine development as well as making contributions to global coordination efforts in the field of malaria vaccine research and development (R&D). In the next five years, EMVI will be coordinating the European Network of Vaccine Research and Development, an European Commission supported action implementing a vaccine development infrastructure for Europe. By stimulating collaboration, cooperation, networking and joint integrated activities across various fields of research and diseases, and by facilitating the federation of research infrastructures, EMVI is acting today as a catalyst for tomorrow's vaccines. © 2010 Landes Bioscience.


PubMed | European Malaria Vaccine Initiative
Type: Journal Article | Journal: Human vaccines | Year: 2010

Over the past ten years, EMVI has continually strived to maintain its main goal of accelerating the development of candidate malaria vaccines by facilitating the translational gap between promising experimental malaria vaccines and subsequent clinical trials in Europe and in Africa. To date, EMVI has funded approximately ten vaccine formulations (antigen-adjuvant combination) by developing GMP materials and sponsoring subsequent human clinical trials. In recent years EMVIs role has expanded into harmonization activities relevant to malaria vaccine development as well as making contributions to global coordination efforts in the field of malaria vaccine research and development (R&D). In the next five years, EMVI will be coordinating the European Network of Vaccine Research and Development, an European Commission supported action implementing a vaccine development infrastructure for Europe. By stimulating collaboration, cooperation, networking and joint integrated activities across various fields of research and diseases, and by facilitating the federation of research infrastructures, EMVI is acting today as a catalyst for tomorrows vaccines.

Loading European Malaria Vaccine Initiative collaborators
Loading European Malaria Vaccine Initiative collaborators